vaccine
Showing 26 - 50 of >10,000
The Role of B7-H4 in Tumor Vaccine
Recruiting
- Glioma
- tumor vaccine
-
Shanghai, Shanghai, ChinaDi Chen
Nov 26, 2023
Tetanus Trial in Shangqiu (Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed)
Recruiting
- Tetanus
- Investigational tetanus vaccine, adsorbed
- Control tetanus vaccine, adsorbed
-
Shangqiu, Henan, ChinaLiangyuan District Center for Disease Control and Prevention
Sep 15, 2023
Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)
Not yet recruiting
- Iron Deficiency Anemia
- Iron-fortified cookies
- +3 more
- (no location specified)
Aug 30, 2023
Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta
Not yet recruiting
- Vaccine Reaction
- COVID-19
- Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
- VidPrevtyn® Beta vaccine (Sanofi/GSK)
-
Paris, FranceCIC 1417 Cochin-Pasteur
Feb 28, 2023
Diphtheria, Tetanus, Pertussis Trial in Xi'an (Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined
Not yet recruiting
- Diphtheria
- +2 more
- Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp)
- +2 more
-
Xi'an, Shanxi, ChinaShaanxi Center for Disease Control and Prevention
Sep 25, 2023
COVID-19 Trial in Paris (Lymph node aspiration / Blood sampling)
Recruiting
- COVID-19
- Lymph node aspiration / Blood sampling
-
Paris, FranceGH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 19, 2023
Vaccine Response Trial in Atlanta, Decatur (Live Attenuated Yellow Fever 17D Vaccine, Quadrivalent seasonal influenza vaccine)
Not yet recruiting
- Vaccine Response
- Live Attenuated Yellow Fever 17D Vaccine
- Quadrivalent seasonal influenza vaccine
-
Atlanta, Georgia
- +2 more
Mar 25, 2023
Vaccine-Preventable Diseases, Typhoid Fever, Cholera Trial in Helsinki (Oral typhoid fever vaccine, Oral cholera vaccine)
Recruiting
- Vaccine-Preventable Diseases
- +2 more
- Oral typhoid fever vaccine
- Oral cholera vaccine
-
Helsinki, FinlandMeilahti Vaccine Research Center, Helsinki University Hospital
Oct 27, 2023
Vaccination; Infection Trial (Vaccine injection)
Not yet recruiting
- Vaccination; Infection
- Vaccine injection
- (no location specified)
Oct 12, 2023
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (VAC?6 vaccine - ?nce at a dose of 106 PFU, VAC?6 vaccine - once at a dose of
Completed
- Smallpox
- +3 more
- VAC∆6 vaccine - оnce at a dose of 10⁶ PFU
- +3 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Feb 28, 2023
COVID-19, Vaccine Hesitancy Trial in Seattle (Vaccine Norms Feedback, Alcohol Norms Feedback)
Recruiting
- COVID-19
- Vaccine Hesitancy
- Vaccine Norms Feedback
- Alcohol Norms Feedback
-
Seattle, WashingtonUniversity of Washington
Mar 14, 2023
Influenza Trial in Santiago de Compostela (Influenza vaccine)
Recruiting
- Influenza
- Influenza vaccine
-
Santiago de Compostela, A Coruña, SpainGeneral Public Health Directorate of Galician Health Service
Nov 15, 2023
SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)
Recruiting
- SARS-CoV-2 Infection
- COVID-19 mRNA Vaccine (ZSVG-02-O)
- COVID-19 Vaccine (Vero Cell) ,Inactivated
-
Dengfeng, Henan, China
- +1 more
Nov 6, 2023
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent
Not yet recruiting
- Seasonal Influenza
- Quadrivalent influenza vaccine(0.25ml)
- +3 more
-
Lu'an, Anhui, China
- +4 more
Sep 15, 2023
COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),
Not yet recruiting
- COVID-19
- +4 more
- Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
- Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
- (no location specified)
Sep 29, 2023
IBD Trial (standard hepatitis B vaccine, accelerated HBV Vaccine)
Not yet recruiting
- Inflammatory Bowel Diseases
- standard hepatitis B vaccine
- accelerated HBV Vaccine
- (no location specified)
Jul 27, 2023
Covid19, Vaccine Refusal, Vaccine Hesitancy Trial in New Orleans (COVID-19 Vaccine Education at the Point of COVID-19 Testing)
Recruiting
- Covid19
- +2 more
- COVID-19 Vaccine Education at the Point of COVID-19 Testing
-
New Orleans, LouisianaXavier University of Louisiana
Dec 19, 2022
NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)
Not yet recruiting
- NSCLC Stage IV
- ALK Fusion Protein Expression
- Peptide vaccine
- (no location specified)
Jul 21, 2023
Polio Trial (polio vaccines: nOPV2, bOPV, IPV)
Not yet recruiting
- Polio
- polio vaccines: nOPV2, bOPV, IPV
- (no location specified)
Nov 2, 2023
Pneumococcal Disease Trial in Hialeah, Elkridge, San Antonio (Low dose multivalent pneumococcal conjugate vaccine formulation A,
Recruiting
- Pneumococcal Disease
- Low dose multivalent pneumococcal conjugate vaccine formulation A
- +3 more
-
Hialeah, Florida
- +2 more
Apr 27, 2023
Rabies Trial in China (5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine)
Not yet recruiting
- Rabies
- 5-dose group of test vaccine
- +3 more
-
Chengdu, Sichuan, China
- +3 more
Jul 23, 2023
Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)
Not yet recruiting
- Human Papillomavirus-Related Carcinoma
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +4 more
Aug 9, 2023
Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),
Not yet recruiting
- Poliomyelitis
- Novel oral poliomyelitis vaccine type 1 (nOPV1)
- +3 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Nov 14, 2023
Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel
Not yet recruiting
- Coronavirus
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Recombinant novel coronavirus protein vaccine (CHO cells)
- (no location specified)
Sep 5, 2023